Form 4 for TECH Bio-Techne
Accepted 2026-04-24 18:06:19 ET · period of report 2026-04-22 · accession 0000914190-26-000081 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-24 18:06 | 2026-04-22 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | +11.3K | 64.4K | +21% | $0 |
| D | 2026-04-24 18:06 | 2026-04-22 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $58.58 | -1,363 | 63.1K | -2% | -$79.8K |
| D | 2026-04-24 18:06 | 2026-04-22 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -11.3K | 61.7K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-22 | M | A | 11,344 | $0.00 | 64,421 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-22 | F | D | 1,363 | $58.58 | 63,058 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-04-22 | M | D | 11,344 | $0.00 | 61,692 | D | $47.60 · — to 2026-08-07 | 11,344 Common Stock | (F1) Fully exercisable. |